Lung Cancer: Related News

On Our Blog

New Leaders in Memorial Sloan-Kettering Thoracic Surgery and Oncology

Thoracic surgeon David Jones and medical oncologist Charles Rudin, internationally recognized leaders in their fields, to head the Thoracic Surgical Service and the Thoracic Oncology Service, respectively.

September 30, 2013

Pictured: Mark Kris, Andreas Rimner, Nabil Pierre Rizk & Max Gomez

Watch Our Experts Discuss the Latest in Lung Cancer Management and Research

In a recent CancerSmart talk focused on lung cancer, three Memorial Sloan-Kettering experts described advances in diagnosis and treatment.

September 3, 2013

Pattern in Lung Cancer Pathology May Predict Cancer Recurrence after Surgery

A Memorial Sloan-Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

August 9, 2013

New Online Tool Helps People Decide Whether to Be Screened for Lung Cancer

A new online decision tool can help current or former smokers determine whether they would benefit from lung cancer screening.

July 30, 2013

Memorial Sloan-Kettering Offers New Type of Lung Cancer Screening for Smokers

Memorial Sloan-Kettering now offers low-dose CT screening for certain smokers at high risk for lung cancer.

June 17, 2013

Meet Thoracic Surgeon Nabil Rizk

Dr. Rizk discusses how the team of experts expedites treatment for patients, and uses minimally invasive techniques to diagnose and treat thoracic cancers when possible.

May 31, 2013

Lung Cancer Patients Will Benefit from New Molecular Testing Guideline

A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies.

April 3, 2013

Pictured: David Finley & Maria Teresa Ruiz Tsukazan

Robot-Assisted Surgery at Memorial Sloan-Kettering

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

February 25, 2013

Memorial Sloan-Kettering's Mark Kris on Partnership with IBM Watson

Medical oncologist Mark Kris discusses how cancer experts are working to train IBM Watson to help assist medical professionals.

February 8, 2013

Study Reveals Immune Response as Potential Biomarker to Predict Recurrence of Lung Cancer

A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

January 3, 2013

Meet Thoracic Surgeon James Huang

Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.

October 31, 2012

Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

September 21, 2012

Tunneling Nanotubes Connect Cancer Cells

Memorial Sloan-Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

September 19, 2012

Meet Thoracic Surgeon David Finley

Dr. Finley, Co-Director of the Complex Airway Program, explains how he lays out a treatment plan with his patients, and determines which type of surgery fits best in the context of their lifestyle.

August 28, 2012

Meet Thoracic Surgeon Inderpal Sarkaria

Thoracic surgeon Inderpal Sarkaria discusses the expertise of Memorial Sloan-Kettering surgeons at performing complex operations to treat cancers of the lung, esophagus, and chest wall.

July 25, 2012

Pulmonary Specialist Peter Bach Discusses New Findings on Benefits of CT Screening for Lung Cancer

In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.

May 21, 2012

Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

May 17, 2012

Surgery’s Vital Role in Treating Cancer

Department of Surgery Chair Peter T. Scardino reflects on the expanding role of surgery at an institution devoted to caring for people with cancer.

March 12, 2012

Lung Cancer Experts Win Wholeness of Life Award

Congratulations to Mark Kris, Chief of the Thoracic Oncology Service, and Ann Culkin, nurse on the Thoracic Oncology Service, for receiving the Wholeness of Life Award 2011 from the HealthCare Chaplaincy.

December 5, 2011

CBS Evening News: Therapy to Target Each Patient's Unique Cancer

Chief of Thoracic Oncology Mark Kris offers his perspective on a promising new tactic for treating lung and other cancers in this story from CBS Evening News with Scott Pelley. The strategy tailors cancer treatment to each individual patient.

November 23, 2011

Memorial Sloan-Kettering Physician-Scientists Present Significant Clinical Cancer Research Advances at ASCO Annual Meeting

In an extraordinary demonstration of excellence, five Memorial Sloan-Kettering physician-scientists were selected to participate in the press program at the 2011 American Society of Clinical Oncology annual meeting, held June 3-7 in Chicago.

July 1, 2011

New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan-Kettering has made an important step forward in efficiently diagnosing gene mutations in patients’ cancers on an individual basis.

June 1, 2010

Image-Guided Radiation Therapy: A New Paradigm in Cancer Care

Many people undergoing cancer treatment receive some form of radiation therapy to shrink and kill a tumor. A relatively new type of radiation therapy — called image-guided radiation therapy (IGRT) — utilizes high-tech imaging with extremely precise radiation beams, ensuring that radiation targets the tumor, sparing nearby healthy tissue. IGRT can be used to treat many types of cancer, including those that develop in the spine, lung, prostate, brain, bladder, esophagus, liver, and bone.

July 1, 2009

Genetic Information Becomes a Vital Part of Clinical Practice

At Memorial Sloan-Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.

October 1, 2008

Related Media Coverage

Lilly Lung Cancer Treatment Raises Survival in Study

Medical oncologist Paul Paik commented on an experimental drug that increased survival among patients with lung cancer in a new study.

Bloomberg

August 13, 2013

Discovery May Help Pinpoint Risk of Lung Cancer Returning after Surgery

A study led by thoracic surgeon Prasad Adusumilli found that an abnormal cell pattern identified in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

HealthDay

August 7, 2013

Task Force Urges Scans for Smokers at High Risk

Epidemiologist Peter Bach commented on draft recommendations from the US Preventive Services Task Force on screening for lung cancer, and Memorial Sloan-Kettering’s lung cancer screening decision tool was highlighted.

The New York Times

July 30, 2013

Low-Dose CT Scans Urged to Detect Lung Cancer in Current, Former Heavy Smokers

Thoracic surgeon Nabil Rizk commented on draft recommendations from the US Preventive Services Task Force on screening for lung cancer.

New York Daily News

July 30, 2013

FDA Approves Pfizer Lung-Cancer Drug

Thoracic oncologist Mark Kris, MD, was interviewed about the FDA approval of crizotinib (Xalkori®), a drug that shrinks tumors in lung-cancer patients with a rare genetic abnormality.

Wall Street Journal

August 26, 2011

Eyewitness News at 5: Benefits and Risks of Lung Cancer Screening

A recently published study found a benefit for screening longtime smokers for lung cancer. Pulmonologist and epidemiologist Peter Bach is quoted.

WABC-TV, Channel 7

June 29, 2011

Tumors In Majority Of Patients With Advanced Lung Cancer Found To Have Genetic Mutations That Can Be Treated With Targeted Therapies

A new study detected one of ten such mutations in 54 percent of the 516 lung cancer patients tested at diagnosis. The results enabled doctors to select the most appropriate drug designed to block the identified mutation and choose other treatment options for those patients whose tumors did not have a mutation.

June 4, 2011

Research Reveals What Drives Lung Cancer's Spread

A new study by researchers at Memorial Sloan-Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

July 2, 2009

Study Shows Drug Combination Improves Outcome for Advanced Non-Small Cell Lung Cancer

A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC).

May 30, 2009

Risk for Lung Cancer Varies Among Smokers

A new study that shows lung cancer risk varies widely among smokers may help individuals and their doctors decide if voluntary screening is appropriate for them.

March 19, 2003

abnormal (ab-NOR-mul)

Not normal. An abnormal lesion or growth may be cancer, premalignant (likely to become cancer), or benign (not cancer).